XML 61 R47.htm IDEA: XBRL DOCUMENT v3.22.1

Business Segments (Tables)

12 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Information about our Operating and Reportable Segments

The tables below summarize information about our operating and reportable segments.

			Year Ended March 31, 2022
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	967,881					$	118,931											$	1,086,812
Cost of sales			419,162						47,004												466,166
Gross profit			548,719						71,927												620,646
Advertising and marketing			138,714						18,629												157,343
Contribution margin			$	410,005					$	53,298											463,303
Other operating expenses																					133,384
Operating income																					$	329,919

*Intersegment revenues of $3.0 million were eliminated from the North American OTC Healthcare segment.

			Year Ended March 31, 2021
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	849,319					$	94,046											$	943,365
Cost of sales			359,100						36,793												395,893
Gross profit			490,219						57,253												547,472
Advertising and marketing			122,857						17,732												140,589
Contribution margin			$	367,362					$	39,521											406,883
Other operating expenses																					109,481
Operating income																					$	297,402

* Intersegment revenues of $3.2 million were eliminated from the North American OTC Healthcare segment.

			Year Ended March 31, 2020
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Total segment revenues*			$	859,368					$	103,642											$	963,010
Cost of sales			372,133						38,654												410,787
Gross profit			487,235						64,988												552,223
Advertising and marketing			127,972						19,222												147,194
Contribution margin			$	359,263					$	45,766											405,029
Other operating expenses																					113,874
Operating income																					$	291,155

*Intersegment revenues of $3.5 million were eliminated from the North America OTC Healthcare segment.

Information about our Revenues from Similar Product Groups

The tables below summarize information about our segment revenues from similar product groups.

			Year Ended March 31, 2022
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	117,868					$	1,455											$	119,323
Cough & Cold			86,855						20,225												107,080
Women's Health			249,136						15,373												264,509
Gastrointestinal			152,191						52,368												204,559
Eye & Ear Care			149,454						13,995												163,449
Dermatologicals			117,173						3,213												120,386
Oral Care			85,239						12,282												97,521
Other OTC			9,965						20												9,985
Total segment revenues			$	967,881					$	118,931											$	1,086,812

			Year Ended March 31, 2021
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	117,775					$	1,367											$	119,142
Cough & Cold			56,158						14,483												70,641
Women's Health			252,535						15,562												268,097
Gastrointestinal			124,755						36,381												161,136
Eye & Ear Care			99,774						10,635												110,409
Dermatologicals			103,998						3,085												107,083
Oral Care			88,903						12,528												101,431
Other OTC			5,421						5												5,426
Total segment revenues			$	849,319					$	94,046											$	943,365

			Year Ended March 31, 2020
(In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Analgesics			$	113,130					$	877											$	114,007
Cough & Cold			87,601						23,505												111,106
Women's Health			239,330						12,221												251,551
Gastrointestinal			130,088						42,820												172,908
Eye & Ear Care			100,245						11,911												112,156
Dermatologicals			100,591						2,421												103,012
Oral Care			83,323						9,882												93,205
Other OTC			5,060						5												5,065
Total segment revenues			$	859,368					$	103,642											$	963,010

Segment Revenue by Geographic Area

Our total segment revenues by geographic area are as follows:

			Year Ended March 31,
			2022						2021						2020
United States			$	910,106					$	799,038					$	812,653
Rest of world			176,706						144,327						150,357
Total			$	1,086,812					$	943,365					$	963,010

Allocation of Long-Term Assets to Segments

Our consolidated goodwill and intangible assets have been allocated to the reportable segments as follows:

March 31, 2022 (In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Goodwill			$	548,291					$	30,685											$	578,976
Intangible assets
Indefinite-lived			2,391,517						85,042												2,476,559
Finite-lived			198,353						21,723												220,076
Intangible assets, net			2,589,870						106,765												2,696,635
Total			$	3,138,161					$	137,450											$	3,275,611

March 31, 2021 (In thousands)			North American OTC Healthcare						International OTC Healthcare												Consolidated
Goodwill			$	546,643					$	31,436											$	578,079
Intangible assets
Indefinite-lived			2,195,617						86,371												2,281,988
Finite-lived			190,462						3,279												193,741
Intangible assets, net			2,386,079						89,650												2,475,729
Total			$	2,932,722					$	121,086											$	3,053,808

Goodwill and Intangible Assets by Geographic Areas

Our goodwill and intangible assets by geographic area are as follows:

			Year Ended March 31,
			2022						2021
United States			$	3,138,161					$	2,932,722
Rest of world			137,450						121,086
Total			$	3,275,611					$	3,053,808

X

- Definition

[Table Text Block] for Goodwill and Intangible Assets by Geographic Areas [Table]

+ References

No definition available.

+ Details

Name:	pbh_GoodwillandIntangibleAssetsbyGeographicAreasTableTextBlock
Namespace Prefix:	pbh_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration